Cizzle Biotechnology Holdings

CIZ · Main Market · Health Care · mcap £6.2m · 1.5p

Beta Briefing, track record and signals & risks are not ready for Cizzle Biotechnology Holdings yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 30 Sep 26 ↗

Revenue: –
Operating profit: −£724k
Net income: −£652k
Free cash flow: −£532k
Net cash: £81k
Market cap: £6.2m
EV / EBIT: –
FCF yield: −8.6%
Price / book: –

Latest half-year · H1 26 vs H1 25 results 30 Sep 26 ↗

Operating profit: −£354k
Net income: −£329k
Cash from operations: −£367k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

As reported Key figures · multi-year

Income statement Balance sheet Cash flow

Half-year Results, published 30 Sep 26 · read the announcement ↗

Consolidated Statement of Comprehensive Income · For the six months ended 30 June 2026

	Group Six months ended 30 June 2026 Unaudited £’000	Group Six months ended 30 June 2025 Unaudited £’000	Group Year ended 31 December 2025 Audited £’000
Revenue	-	-	-
Cost of Sales	-	-	-
Gross Profit	-	-	-
Interest receivable	-	1	2
Administrative Expenses
-on going administrative expenses	(354)	(346)	(711)
-share option charge	-	(10)	(20)
- loss on sale of investment	-	(26)	-
Net fair value loss on financial asset measured at fair value through profit or loss	-	-	(22)
Total administrative expenses including exceptional items	(354)	(382)	(753)
Operating Loss and loss before income tax	(354)	(381)	(751)
Income tax	25	13	60
Loss and total comprehensive income for the period attributable to the equity shareholders of the parent	(329)	(368)	(691)
Earnings per share Loss- basic and diluted – pence	(0.08)p	(0.09)p	(0.17)p

Consolidated Statement of Financial Position · as at 30 June 2026 · Property, plant and equipment · Total Non-Current Assets

	Group 30 June 2026 Unaudited £’000	Group 30 June 2025 Unaudited £’000	Group 31 Dec 2025 Audited £’000
Non-Current Assets
Current Assets
Inventories	-	1	-
Trade and other receivables	109	72	127
Cash and cash equivalents	81	182	116
Total Current Assets	190	255	243
Total Assets	191	257	245
Equity
Ordinary shares	3,510	3,507	3,507
Share premium	36,139	35,911	35,911
Share capital reduction reserve	10,081	10,081	10,081
Share option reserve	519	650	519
Convertible loan reserve	270	-	186
Share warrant reserve	80	-	63
Reverse acquisition reserve	(40,021)	(40,021)	(40,021)
Retained losses	(10,915)	(10,404)	(10,586)
Total equity	(337)	(276)	(340)
Liabilities
Current liabilities
Trade and other payables	528	383	585
Convertible debt	-	150	-
Total current liabilities	528	533	585
Total equity and liabilities	191	257	245

Consolidated Statement of Cash Flows · For the six months ended 30 June 2026

	Group 6 Months ended 30 June 2026 Unaudited £’000	Group 6 Months ended 30 June 2025 Unaudited £’000	Group 12 Months ended 31 Dec 2025 Audited £’000
Cash flow from operating activities
Operating loss before tax	(354)	(381)	(751)
Adjustment for
Net fair value loss on financial assets measured at fair value through profit or loss	-	-	22
Loss on sale of investment	-	22	-
Share option charge	-	10	20
Depreciation charge	1	-	-
Operating cash flow before working capital movements	(353)	(349)	(709)
Decrease in inventories	-	1	2
Decrease / (increase) in trade and other receivables	12	6	(3)
(Decrease) / increase in trade and other payables	(57)	(27)	176
Cash used in operations	(398)	(369)	(534)
Tax received	31	38	38
Net cash used in operating activities	(367)	(331)	(496)
Cash flow from financing activities
Conversion of debt to equity (net of issue costs)	(18)	-	-
Issue of convertible debt	350	150	249
Net cash inflow from financing activities	332	150	249
Cash flow from investing activities
Purchase of laboratory equipment	-	(2)	(2)
Net cash expended in investing activities	-	(2)	(2)
Net (decrease) / increase in cash and cash equivalents	(35)	(183)	(249)
Cash and cash equivalents at the start of the period	116	365	365
Cash and cash equivalents at the end of the period	81	182	116

As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25
Revenue to operating profit
Gross profit	0.0	0.0
Operating profit	(0.7)	(0.8)
Share-based payments	(0.0)	(0.0)
Operating profit to net income
Profit before tax	(0.7)	(0.8)
Tax	0.1	0.1
Net income (owners)	(0.7)	(0.7)
Per share
EPS basic	(0.2p)	(0.2p)
EPS diluted	(0.2p)	(0.2p)

	H1 26	vs H1 25	H2 25	H1 25
Revenue to operating profit
Gross profit	0.0	n/m	0.0	0.0
Operating profit	(0.4)	n/m	(0.4)	(0.4)
Share-based payments	0.0	n/m	(0.0)	(0.0)
Operating profit to net income
Profit before tax	(0.4)	n/m	(0.4)	(0.4)
Tax	0.0	n/m	0.0	0.0
Net income (owners)	(0.3)	n/m	(0.3)	(0.4)
Per share
EPS basic	(0.1p)	–	(0.1p)	(0.1p)
EPS diluted	(0.1p)	–	(0.1p)	(0.1p)

	LTM Jun 26	FY 25
Operating activities
Cash from operations	(0.5)	(0.5)
Tax paid	0.0	0.0
Investing activities
Capex (PP&E)	0.0	(0.0)

	H1 26	vs H1 25	H2 25	H1 25
Operating activities
Cash from operations	(0.4)	n/m	(0.2)	(0.3)
Tax paid	0.0	n/m	0.0	0.0
Investing activities
Capex (PP&E)	0.0	n/m	0.0	(0.0)

	Latest Jun 26	FY 25
Non-current assets
Property, plant & equipment	0.0	0.0
Non-current assets	0.0	0.0
Current assets
Inventories	0.0	0.0
Trade receivables	0.1	0.1
Cash	0.1	0.1
Current assets	0.2	0.2
Total assets	0.2	0.2
Current liabilities
Trade payables	0.5	0.6
Borrowings, current	0.0	0.0
Current liabilities	0.5	0.6
Equity
Total equity	(0.3)	(0.3)

	H1 26	H2 25	H1 25
Non-current assets
Property, plant & equipment	0.0	0.0	0.0
Non-current assets	0.0	0.0	0.0
Current assets
Inventories	0.0	0.0	0.0
Trade receivables	0.1	0.1	0.1
Cash	0.1	0.1	0.2
Current assets	0.2	0.2	0.3
Total assets	0.2	0.2	0.3
Current liabilities
Trade payables	0.5	0.6	0.4
Borrowings, current	0.0	0.0	0.1
Current liabilities	0.5	0.6	0.5
Equity
Total equity	(0.3)	(0.3)	(0.3)

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.